Clinical trial
Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer
NCT02494869 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- July 31, 2015
- Completion date
- July 31, 2027
- Enrollment
- 75 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
high risk for developing breast cancer